Health
Selecting SARS-CoV-2 inhibitors in human airway epithelial cells – News-Medical.Net
In a recent article currently available on the bioRxiv* preprint server, researchers from Belgium and the U.S. demonstrated a robust replication model for the severe…
In a recent article currently available on the bioRxiv* preprint server, researchers from Belgium and the U.S. demonstrated a robust replication model for the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) isolates in primary human epithelial cells at the air-liquid interface and appraised the antiviral effect of selected viral replication inhibitors.
The vaccination campaign is our current answer against the ongoing spread of SARS-CoV-2 and coronavirus disease (COVID-19) pandemic….
-
General23 hours agoSector warns Coalition’s plan to limit overseas students ‘straight out of Trump’s playbook’
-
Noosa News23 hours agoMeasles alert issued across popular south-east attractions
-
General15 hours agoPope Francis makes surprise first appearance after hospital stay
-
Noosa News7 hours agoQueen Street Mall to get a 3D digital billboard; Dutton dumps controversial plans to end flexible work; Measles alert for tourist hotspots